1,2,4,5-Tetracyanobenzene (TCNB) is a highly electron-deficient aromatic compound. It is a strong electron acceptor and forms charge-transfer complexes with electron-rich compounds, such as aromatic hydrocarbons. TCNB can be synthesized by the reaction of 1,2,4,5-tetrabromobenzene with cuprous cyanide. It is known to be a powerful oxidizing agent and has been studied for its potential use in organic electronics. Its high electron affinity makes it a suitable candidate for organic semiconductors, photovoltaic devices, and other electronic applications. TCNB has also been investigated for its potential applications in molecular electronics due to its ability to form stable charge-transfer complexes.'
```
1,2,4,5-tetracyanobenzene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 12838 |
SCHEMBL ID | 56906 |
MeSH ID | M0368145 |
Synonym |
---|
1,2,4,5-benzentetrakarbonitril |
c10h2n4 |
s-tetracyanobenzene |
1,2,4,5-benzenetetracarbonitrile |
1,2,4,5-benzentetrakarbonitril [czech] |
pyromellitic tetranitrile |
pyromellitonitrile |
1,2,4,5-benzenetetranitrile |
pyromellitic nitrile |
pyromellitic acid tetranitrile |
pyromellitotetranitrile |
712-74-3 |
inchi=1/c10h2n4/c11-3-7-1-8(4-12)10(6-14)2-9(7)5-13/h1-2 |
1,2,4,5-tetracyanobenzene, 97% |
1,2,4,5-tetracyanobenzene |
benzene-1,2,4,5-tetracarbonitrile |
T0988 |
AKOS005254531 |
GEO-00253 |
FT-0606237 |
SCHEMBL56906 |
DTXSID00221399 |
sym-tetracyanobenzene |
benzene, 1,2,4,5-tetracyano- |
FAAXSAZENACQBT-UHFFFAOYSA-N |
W-200494 |
AC-27925 |
CS-W008102 |
mfcd00043481 |
CS-17328 |
1-cbz-3-aminopiperidine |
YSWG012 |
SY050625 |
A851476 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.33) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |